Understanding how carfentanil causes breathing problems and death
Mechanism and Countermeasure of Carfentanil-induced Respiratory Disorder and Death
This study is looking into how carfentanil, a very strong opioid, can harm breathing and aims to find ways to help people who might be affected by it, especially during an overdose.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lovelace Biomedical Research Institute NIH-funded |
| Lab location | 1 site (Albuquerque, United States) |
| Project ID | NIH-11078227 on NIH RePORTER |
What this research studies
This research investigates the dangerous effects of carfentanil, a potent synthetic opioid, which can lead to severe respiratory disorders and death. The study aims to uncover the mechanisms by which carfentanil affects the body's ability to breathe, particularly focusing on how it interacts with specific receptors in the brain that control respiration. By examining these interactions, the researchers hope to identify effective countermeasures to prevent or treat carfentanil-induced respiratory failure. The approach includes both animal models and potential therapeutic interventions to improve outcomes for those affected by opioid overdoses.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced or are at risk of opioid overdose, particularly those exposed to carfentanil.
Not a fit: Patients who are not affected by opioid use or who do not have respiratory disorders related to opioid exposure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively counteract the life-threatening respiratory effects of carfentanil and similar opioids.
How similar studies have performed: While there have been studies on opioid overdose treatments, the specific mechanisms and countermeasures for carfentanil-induced respiratory issues are still largely untested, making this research novel.
Where this research is happening
Albuquerque, United States
- Lovelace Biomedical Research Institute — Albuquerque, United States (Active)
Researchers
- Principal investigator: Xu, Fadi — Lovelace Biomedical Research Institute
- Study coordinator: Xu, Fadi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.